PHARMAC widens access to funded treatments for multiple sclerosis

PHARMAC

12 February 2021 - PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March 2021.

1,800 people with multiple sclerosis will be able to stay on their treatment for longer, and some who had stopped funded treatment may now be eligible to restart.

Read PHARMAC press release

Michael Wonder

Posted by:

Michael Wonder